CD4 ≤ 200 | ||
---|---|---|
OR* | 95% CI | |
Limited Activity score | ||
None | 1 | |
1–5 | 3.58 | 0.91 – 14.2 |
> 5 | 24.7 | 4.85 – 125 |
Number of impairments | 1.01 | 0.94 – 1.12 |
Antiretroviral use | 0.28 | 0.08 – 0.93 |
CD4 > 200 | ||
OR* | 95% CI | |
Limited Activity score | ||
None | 1 | |
1–5 | 2.67 | 1.40 – 5.12 |
> 5 | 8.56 | 3.90 – 18.8 |
Number of impairments | 1.19 | 1.12 – 1.25 |
Pain | ||
None | 1 | |
Some/mild | 1.31 | 0.71 – 2.44 |
Mod/severe | 1.78 | 0.85 – 3.75 |
Antiretroviral use | 1.39 | 0.83 – 2.35 |